Second-look laparotomy for ovarian cancer provides reliable prognostic information and improves survival

Gynecologic Oncology

Volumn 67, Issue 1, 1997, Pages 88-94

  Friedman, Richard L ^a   Eisenkop, Scott M ^a   Wang, He Jing ^b  

^a The Women's Cancer Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; LAPAROTOMY; OVARY CANCER; PRIORITY JOURNAL;

EID: 0031260294     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4825     Document Type: Article

References (20)

1. 1. Creasman WT: Second-look laparotomy in ovarian cancer. Gynecol Oncol 55:(Pt 2), S122-S127, 1994
2. 2. Potter ME, Hatch KD, Soong SJ, Partridge EE, Austin JM Jr, Shingleton HM: Second-look laparotomy and salvage therapy: A research modality only? Gynecol Oncol 44:3-9, 1992
3. 3. Podratz KC, Kinney WK: Second-look operation in ovarian cancer. Cancer 71(Suppl 4):1551-1558, 1993
4. 4. Podratz KC, Cliby WA: Second-look surgery in the management of epithelial ovarian carcinoma. Gynecol Oncol 55:(Pt 2), S128-S133, 1994
5. 111InCyt103 prior to second-look laparotomy. A pilot study. Am J Clin Oncol 17:331-334, 1994
6. 6. Pectisades D, Kayianni H, Facou A, Bobotas V, Barbounis V, Zis J, Athanassiou A: Correlation of abdominal computed tomography scanning and second-look operation findings in ovarian cancer patients. Am J Clin Oncol 14:457-462, 1991
7. 7. De Rosa V, Mangoni di Stefano ML, Brunetti A, Caraco C, Graziano R, Gallo MS, Maffeo A: Computed tomography and second-look surgery in ovarian cancer. Correlation, actual role and limitations of CT scan. Eur J Gynaecol Oncol 16:123-129, 1995
8. 8. Folk JJ, Botsford M, Musa AG: Monitoring cancer antigen 125 levels in induction chemotherapy for epithelial ovarian carcinoma and predicting outcome of second-look procedure. Gynecol Oncol 57:178-182, 1995
9. 9. Lippman SM, Alberts DS, Slymen DJ, Weiner S, Aristizabal SA, Luditch A, et al: Second-look laparotomy in epithelial ovarian carcinoma: Prognostic factors associated with survival duration: Cancer 61:2571-2577, 1988
10. 10. Hoskins WJ, Rubin SC, Dulaney E, Chapman D, Almadrones L, Saigo P, et al: Influence of secondary cytoreduction at the time of second-look laparotomy on the survival of patients with epithelial ovarian carcinoma. Gynecol Oncol 34:365-371, 1989
11. 11. Miller DSM, Spirtos NM, Ballon SC, Cox RS, Soriero OM, Teng NH: Critical reassessment of second-look exploratory laparotomy for epithelial ovarian carcinoma. Cancer 69:502-510, 1992
12. 12. Chapet S, Berger C, Pignon A, Calais G, Fetissof F, Reynaud-Boougnoux A, et al: Abdomino-pelvic irradiation after second-look laparotomy for stage III ovarian carcinoma. Eur J Obstet Gynecol Reprod Biol 62:43-48, 1995.
13. 13. Ozols RF, Rubin SC, Thomas GM, Robboy SC: Epithelial Ovarian Cancer, in WJ Hoskins, SC Ferez, RC Young, (eds): Gynecologic Oncology. Philadelphia, Lippincott-Raven, 1996
14. 14. Childers JM, Lang J, Surwit EA, Hatch KD: Laparoscopic surgical staging of ovarian cancer. Gynecol Oncol 59:25-33, 1995
15. 15. Copeland LJ, Vacarello L, Lewandowski DS: Second-look laparotomy in epithelial ovarian cancer. Obstet Gynecol Clin North Am 21:155-166, 1994.
16. 16. Rubin SC, Hoskins WJ, Saigo, PJ, Chapman D, Hakes TB, Markman M, et al: Prognostic factors for recurrence following negative secondlook laparotomy in ovarian cancer patients treated with platinum-based chemotherapy. Gynecol Oncol 42:137-141, 1991
17. 17. Gershenson DM, Copeland LJ, Wharton JT, Atkinson EN, Sneige N, Edwards CL, et al: Prognosis of surgically determined complete responders in advanced ovarian cancer. Cancer 55:1129-1135, 1985
18. 18. Eisenkop SM, Friedman RL, Wang H: Secondary cytoreductive surgery for recurrent ovarian cancer. A prospective study. Cancer 76:1606-1614, 1995.
19. 19. Bristow RE, Legasse LD, Karlin BY: Secondary surgical cytoreduction for advanced epithelial ovarian cancer: Patient selection and review of the literature. Cancer 78:2049-2062, 1996
20. 20. McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, et al: Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 334:1-6, 1996